This is often necessary for the treatment of symptoms, e.g. tremor, ataxia, nystagmus or bladder dysfunction, and even standard when it comes to the first-line immunotherapy of neuromyelitis optica spectrum diseases and MOG-antibody-associated diseases. Here, MOG is linked to Ataxia.